Delivery Order SPE2DB24D2101-SPE2DB24FKFKC
Award Date
7/22/24
Potential Completion Date
7/23/24
Potential Value
$2.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $39,774.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4564658926 SUCRALFATE 1 GM TABLET 90S, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was open to general competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that holds significant Indefinite Delivery...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,663,747 units of Sucralfate 1 GM/10 ML Suspension in 420 ML containers. The contract has a firm fixed price of $1,649.74 and a completion date of September 4, 2024. This contract is not a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,730.56, is for the supply of Sucralfate 1 gm/10 ml suspension in 420 ml bottles. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,339.50, is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract has an ultimate completion date of October 30, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sucralfate 1 GM/10 ML Suspension 473 ML, a medication used to treat certain stomach and esophageal conditions. The contract has a firm fixed price of $1,595.74 and a completion date of May 20, 2025. The contract is not set aside and is an open competition award. Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price of $2,482.57 and a completion date of June 30, 2025. The contract is not a set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of sucralfate 1 gram tablets. The contract has a firm fixed price and a ceiling value of $9,144.83. The period of performance extends to June 13, 2025. This contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop...
The federal contract award is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML quantities. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $1,455.06 with a Firm Fixed Price pricing type. The period of performance runs through May 16, 2023. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, with ID SPE2DB22D2006|SPE2DB24FV9UL, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of sucralfate 1 gram tablets, with a ceiling value of $39,810.57 and a completion date of April 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML containers to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under a $1,095.67 firm fixed price delivery order. There was no set-aside designation for this award. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen....